This is the best summary I could come up with:
The maker of weight-loss drug, Wegovy, has become Europe’s most valuable firm dethroning the French luxury conglomerate LVMH.
Wegovy is an obesity treatment that is taken once a week which tricks people into thinking that they are already full, so they end up eating less and losing weight.
Famous personalities such as Elon Musk are among the reported users of the drug, which has captivated Hollywood and the public more widely since it was approved by regulators in the US in 2021.
There has been a global shortage of the jabs so only limited stock arrived for the UK’s National Health System (NHS).
In the UK, NHS guidelines say patients can only access Wegovy, which contains the drug semaglutide, if they are significantly overweight and have weight-related health problems.
According to the Organisation for Economic Co-operation and Development (OECD), nearly one in three adults are obese in the UK which is the highest level in Europe.
The original article contains 307 words, the summary contains 156 words. Saved 49%. I’m a bot and I’m open source!
